Class action lawsuits have put into question nutraceutical marketing practices, effectiveness and safety, but whether they fall under federal or state guidelines seems to be driven by aggressive plaintiffs and more. With the increasing use of social media networks and eCommerce, nutraceutical product manufacturers lack clear guidance on what requirements, from multiple governing organizations, they are to meet.
Drug and medical device attorney Kim Schmid explores the authority of organizations like the FTC and FDA, and what this means for the defense of nutraceutical manufacturers, in "Attack on Multiple Fronts in Nutraceutical Marketing: The threat of FTC, FDA and Consumer Class Actions."
Published in Food and Drug Law Institute Update magazine. Reprinted with permission from FDLI.